{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:09:26Z","timestamp":1793387366426,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jagp.2021.04.014","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T12:16:14Z","timestamp":1620821774000},"page":"32-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial"],"prefix":"10.1016","volume":"30","author":[{"given":"D.P.","family":"Devanand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Crocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent P.","family":"Forester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipsit V.","family":"Vahia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Simon-Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luminita","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Huey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Deliyannides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory H.","family":"Pelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2021.04.014_bib0001","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.bp.114.148403","article-title":"Longitudinal course of behavioural and psychological symptoms of dementia: systematic review","volume":"209","author":"van der Linde","year":"2016","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1041610214001963","article-title":"Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition","volume":"27","author":"Cummings","year":"2015","journal-title":"Intl Psychogeriatr"},{"key":"10.1016\/j.jagp.2021.04.014_bib0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archpsyc.1997.01830150083012","article-title":"The course of psychopathologic symptoms in mild to moderate Alzheimer's disease","volume":"54","author":"Devanand","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0004","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/appi.ajp.157.5.708","article-title":"Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging","volume":"157","author":"Lyketsos","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0005","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.62.10.1601","article-title":"Delusions and hallucinations are associated with worse outcome in Alzheimer disease","volume":"62","author":"Scarmeas","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jagp.2021.04.014_bib0006","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/archneur.64.12.1755","article-title":"Disruptive behavior as a predictor in Alzheimer disease","volume":"64","author":"Scarmeas","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jagp.2021.04.014_bib0007","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1017\/S1041610210000244","article-title":"Predictors of nursing home admission among Alzheimer's disease patients with psychosis and\/or agitation","volume":"23","author":"Miller","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2021.04.014_bib0008","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2021.04.014_bib0009","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1176\/appi.ajp.2012.11101529","article-title":"Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia","volume":"169","author":"Brodaty","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jagp.2020.01.190","article-title":"Aggression prevention training for individuals with dementia and their caregivers: a randomized controlled trial","volume":"28","author":"Kunik","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0011","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrneurol.2009.39","article-title":"Management of agitation and aggression associated with Alzheimer disease","volume":"5","author":"Ballard","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jagp.2021.04.014_bib0012","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1114058","article-title":"Relapse risk after discontinuation of risperidone in Alzheimer's disease","volume":"367","author":"Devanand","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2021.04.014_bib0013","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2021.04.014_bib0014","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/gps.1792","article-title":"The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials","volume":"22","author":"Katz","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0015","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2021.04.014_bib0016","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jagp.2021.04.014_bib0017","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","article-title":"Alzheimer's disease cooperative study group: chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease","volume":"68","author":"Tariot","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S1092852918001360","article-title":"New hope for Alzheimer's dementia as prospects for disease modification fade: symptomatic treatments for agitation and psychosis","volume":"23","author":"Stahl","year":"2018","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jagp.2021.04.014_bib0019","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2021.04.014_bib0020","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/ijms18122679","article-title":"An oldie but goodie: lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms","volume":"18","author":"Won","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jagp.2021.04.014_bib0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004714-198202000-00013","article-title":"Successful treatment of dementia with lithium","volume":"2","author":"Havens","year":"1982","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2021.04.014_bib0022","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/gps.1964","article-title":"A feasibility and tolerability study of lithium in Alzheimer's disease","volume":"23","author":"Macdonald","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0023","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/WAD.0000000000000161","article-title":"Low-dose Lithium treatment for agitation and psychosis in Alzheimer's disease and Frontotemporal dementia: a case series","volume":"31","author":"Devanand","year":"2017","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jagp.2021.04.014_bib0024","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4088\/JCP.08m04606","article-title":"Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study","volume":"70","author":"Hampel","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1192\/bjp.2019.76","article-title":"Disease modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomized controlled trial","volume":"215","author":"Forlenza","year":"2019","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cct.2018.05.019","article-title":"Lithium treatment for agitation in Alzheimer's disease (Lit-AD): clinical rationale and study design","volume":"71","author":"Devanand","year":"2018","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jagp.2021.04.014_bib0027","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2021.04.014_bib0028","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2021.04.014_bib0029","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jagp.2021.04.014_bib0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/JCP.0b013e31823607db","article-title":"Lithium-induced renal insufficiency: a longitudinal study of creatinine increases in intellectually disabled adults","volume":"31","author":"Janowsky","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2021.04.014_bib0031","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/j.ackd.2010.03.010","article-title":"CKD and ESRD in the elderly: current prevalence, future projections, and clinical significance","volume":"17","author":"Stevens","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jagp.2021.04.014_bib0032","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1176\/appi.ajp.2017.15050657","article-title":"GERI-BD: a randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder","volume":"174","author":"Young","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0033","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2190\/UURL-2RYU-WRYD-EY3K","article-title":"A measure of primary sociobiological functions","volume":"6","author":"Katz","year":"1976","journal-title":"Int J Health Serv"},{"key":"10.1016\/j.jagp.2021.04.014_bib0034","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward","year":"1997","journal-title":"Biometrics"},{"key":"10.1016\/j.jagp.2021.04.014_bib0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jmp.2012.08.001","article-title":"Default Bayes factors for ANOVA designs","volume":"56","author":"Rouder","year":"2012","journal-title":"J Math Psychol"},{"key":"10.1016\/j.jagp.2021.04.014_bib0036","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1192\/bjp.2019.195","article-title":"The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy Body Dementia: 12-year longitudinal cohort study","volume":"216","author":"Vik-Mo","year":"2020","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0037","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00002512-200016030-00002","article-title":"Differential pharmacokinetics of lithium in elderly patients","volume":"16","author":"Sproule","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2021.04.014_bib0038","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","article-title":"Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD","volume":"168","author":"Vigen","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0039","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/archpsyc.65.11.1331","article-title":"Lithium treatment and risk of dementia","volume":"65","author":"Kessing","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.bp.114.154047","article-title":"Lithium treatment and risk for dementia in adults with bipolar disorder: population-based cohort study","volume":"207","author":"Gerhard","year":"2015","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2021.04.014_bib0041","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00002512-200522010-00003","article-title":"Managing bipolar disorder in the elderly: defining the role of the newer agents","volume":"22","author":"Sajatovic","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2021.04.014_bib0042","first-page":"104","article-title":"Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease","volume":"10","author":"Nunes","year":"2013","journal-title":"Curr Alzheimer Res"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121003122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121003122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:32:16Z","timestamp":1761021136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748121003122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1064748121003122"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2021.04.014","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2021.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}